Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about MCRB
Recent news which mentions MCRB
< Previous
1
2
3
Next >
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
Tickers
ABSI
ADGI
APLS
AXNX
Tags
General
MDXG
PIRS
From
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 27, 2021
Tickers
ALZN
ATXI
BAND
BLCT
Tags
Benzinga
TNP
52/Week Lows
From
Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
Tickers
ABVC
ACAD
ACET
ADMA
Tags
GOVX
BMEA
MXCT
From
Benzinga
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
August 18, 2021
Tickers
ABBV
ABSI
ABVC
ACAD
Tags
MBRX
GNCA
NBTX
From
Benzinga
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
August 17, 2021
Tickers
ABSI
ABVC
ACAD
ACHV
Tags
NAOV
ONCR
KNSA
From
Benzinga
Stocks That Hit 52-Week Lows On Monday
August 16, 2021
Tickers
IRCP
JRJC
JUPW
KNSA
Tags
YY
VIEW
TLSA
From
Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
August 12, 2021
Tickers
ABCL
ACET
ACHV
ADGI
Tags
PAVM
SYBX
TRVI
From
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
August 11, 2021
Tickers
ICLK
INNV
KMDA
KNSA
Tags
ICLK
USAS
ZGNX
From
Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
Tickers
ACAD
ACHV
ADMA
AKRO
Tags
CRNX
VIVE
CTMX
From
Benzinga
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
August 03, 2021
Tickers
ABSI
ACET
ADCT
ADVM
Tags
ABSI
GANX
RHHBY
From
Benzinga
Recap: Seres Therapeutics Q2 Earnings
August 03, 2021
Tickers
MCRB
Tags
News
Benzinga
Earnings
From
Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
Tickers
ABUS
ADCT
AERI
ALDX
Tags
HZNP
ANIP
YMAB
From
Benzinga
Analyst Ratings For Seres Therapeutics
July 23, 2021
Tickers
MCRB
Tags
BZI/AAR
Analyst Ratings
MCRB
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 23, 2021
July 23, 2021
Tickers
ADVM
AGESY
AGFY
AHH
Tags
CAHPF
IS
UCBJY
From
Benzinga
10 Biggest Price Target Changes For Friday
July 23, 2021
Tickers
ADVM
ARVN
CVLT
DPZ
Tags
SAM
ADVM
ARVN
From
Benzinga
61 Biggest Movers From Yesterday
July 23, 2021
Tickers
ABSI
AEHR
AFIB
APDN
Tags
ZENV
DWSN
VERB
From
Benzinga
Mid-Afternoon Market Update: Dow Rises Over 50 Points; ImmunoPrecise Antibodies Shares Spike Higher
July 22, 2021
Tickers
ACMR
ADBE
BASE
IPA
Tags
BASE
Markets
IPA
From
Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
July 22, 2021
Tickers
APDN
ARVN
AUUD
BASE
Tags
WISA
FBRX
ZVO
From
Benzinga
Mid-Day Market Update: Crude Oil Up 1.5%; Seres Therapeutics Shares Plunge
July 22, 2021
Tickers
ACMR
IPA
JUPW
MCRB
Tags
WISA
Global
Earnings
From
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 22, 2021
Tickers
AFIB
CABA
CFMS
ERYP
Tags
EVLO
Benzinga
NRXP
From
Benzinga
Why Seres Therapeutics Stock Is Crashing Today
July 22, 2021
Tickers
MCRB
NSRGY
Tags
MCRB
Market News
NSRGY
From
Motley Fool
Mid-Morning Market Update: Markets Mostly Lower; AT&T Beats Q2 Estimates
July 22, 2021
Tickers
ACMR
IPA
JUPW
MCRB
Tags
Earnings
Global
WISA
From
Benzinga
The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO
July 22, 2021
Tickers
ABT
ARVN
AVTE
BHVN
Tags
FDA
IPOs
NRXP
From
Benzinga
Seres Therapeutics Stock Plunges As Ulcerative Colitis Candidate Disappoints In Mid-Stage Study
July 22, 2021
Tickers
MCRB
Tags
ulcerative colitis
General
Briefs
From
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.